Clinical studies recruiting near Tulsa

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · St. John Medical Center · Joseph Broderick, MD · NCT07227246 ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valve
NA · Oklahoma Heart Institute · Edwards Lifesciences · NCT05172973 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Oklahoma Cancer Specialists and Research Institute, LLC ( Si · Merck Sharp & Dohme LLC · NCT06393374 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Saint Francis Children's Hospital · National Cancer Institute (NCI) · NCT06172296 Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
EARLY_Phase 1 · Stephenson Cancer Center- Tulsa · University of Oklahoma · NCT05921253 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · DelRicht Research · Kallyope Inc. · NCT07674654 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Oklahoma Cancer Specialists and Research Institute, LLC ( Si · Merck Sharp & Dohme LLC · NCT07216703 A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Phase 3 · Urologic Specialists of Oklahoma · UroGen Pharma Ltd. · NCT06774131 Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
Phase 2 · Laureate Institute for Brain Research · Laureate Institute for Brain Research, Inc. · NCT06263660 Nectero EAST System Clinical Study
Phase 2/Phase 3 · Oklahoma Heart Institute · Nectero Medical, Inc. · NCT06001918 A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Phase 2 · DelRicht Research · Eli Lilly and Company · NCT05986292 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Oklahoma Cancer Specialists and Research Institute-Tulsa · NRG Oncology · NCT05174169 Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · Central States Research · Eli Lilly and Company · NCT07353931 A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate
Phase 3 · Teva Investigational Site 12155 · Teva Branded Pharmaceutical Products R&D LLC · NCT06664619 Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia
Phase 2 · Saint Francis Children's Hospital · St. Jude Children's Research Hospital · NCT06390319 Pan Tumor Rollover Study
Phase 2 · Local Institution - 0246 · Bristol-Myers Squibb · NCT03899155 GEMINI-NSCLC: NSCLC Biomarker Study
Phase N/A · Oklahoma Cancer Specialists and Research Institute · Tempus AI · NCT05236114 Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Phase 4 · Saint Francis Children's Hospital · St. Jude Children's Research Hospital · NCT06289673 A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type
Phase 3 · Essential Medical Research · Hoffmann-La Roche · NCT07351058 A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Phase 3 · DelRicht Research - Tulsa · Crystalys Therapeutics · NCT07089888 A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson'
Phase 3 · The Movement Disorder Clinic of Oklahoma · Hoffmann-La Roche · NCT07174310 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · Massive Bio SYNERGY-AI site · Massive Bio, Inc. · NCT03452774 Mitigating PTSD-CUD After Sexual Assault
Phase 1/Phase 2 · Tulsa Forensic Nursing · University of Nevada, Las Vegas · NCT05989841 Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Oklahoma Cancer Specialists and Research Institute-Tulsa · National Cancer Institute (NCI) · NCT05256225 Sacral Neuromodulation for Male Overactive Bladder (MOAB)
NA · Utica Park Urology · Axonics, Inc. · NCT06511141 Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
Phase 2 · Saint Francis Children's Hospital · St. Jude Children's Research Hospital · NCT06533748 Effects of Acute Exercise and Ibuprofen on Symptoms, Immunity, and Neural Circuits in Bipolar Depression
Phase 1/Phase 2 · Laureate Institute for Brain Research · Laureate Institute for Brain Research, Inc. · NCT06088732 Project: Every Child for Younger Patients With Cancer
Phase N/A · Natalie Warren Bryant Cancer Center at Saint Francis · Children's Oncology Group · NCT02402244 Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Phase 2/Phase 3 · Corxel Investigational Site · Corxel Pharmaceuticals · NCT06990867 Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab
Phase 2 · Oklahoma Cancer Specialists and Research Institute-Tulsa · NRG Oncology · NCT05327686

Look up another city

Look up another condition